Literature DB >> 20233039

Botulinum neurotoxin: a marvel of protein design.

Mauricio Montal1.   

Abstract

Botulinum neurotoxin (BoNT), the causative agent of botulism, is acknowledged to be the most poisonous protein known. BoNT proteases disable synaptic vesicle exocytosis by cleaving their cytosolic SNARE (soluble NSF attachment protein receptor) substrates. BoNT is a modular nanomachine: an N-terminal Zn(2+)-metalloprotease, which cleaves the SNAREs; a central helical protein-conducting channel, which chaperones the protease across endosomes; and a C-terminal receptor-binding module, consisting of two subdomains that determine target specificity by binding to a ganglioside and a protein receptor on the cell surface and triggering endocytosis. For BoNT, functional complexity emerges from its modular design and the tight interplay between its component modules--a partnership with consequences that surpass the simple sum of the individual component's action. BoNTs exploit this design at each step of the intoxication process, thereby achieving an exquisite toxicity. This review summarizes current knowledge on the structure of individual modules and presents mechanistic insights into how this protein machine evolved to this level of sophistication. Understanding the design principles underpinning the function of such a dynamic modular protein remains a challenging task.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20233039     DOI: 10.1146/annurev.biochem.051908.125345

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  164 in total

Review 1.  Dendritic SNAREs add a new twist to the old neuron theory.

Authors:  Saak V Ovsepian; J Oliver Dolly
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-11       Impact factor: 11.205

2.  Structures of engineered Clostridium botulinum neurotoxin derivatives.

Authors:  Geoffrey Masuyer; Patrick Stancombe; John A Chaddock; K Ravi Acharya
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-11-25

Review 3.  Exploring the role of host cell chaperones/PPIases during cellular up-take of bacterial ADP-ribosylating toxins as basis for novel pharmacological strategies to protect mammalian cells against these virulence factors.

Authors:  Holger Barth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-01       Impact factor: 3.000

4.  SNARE tagging allows stepwise assembly of a multimodular medicinal toxin.

Authors:  Frédéric Darios; Dhevahi Niranjan; Enrico Ferrari; Fan Zhang; Mikhail Soloviev; Andreas Rummel; Hans Bigalke; Jason Suckling; Yuri Ushkaryov; Nikolay Naumenko; Anastasia Shakirzyanova; Rashid Giniatullin; Elizabeth Maywood; Michael Hastings; Thomas Binz; Bazbek Davletov
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

5.  Effect of botulinum neurotoxin type A (BoNTA) on the morphology and viability of 3T3 murine fibroblasts.

Authors:  Cindy Bandala; Juan Luis Terán-Melo; Maricruz Anaya-Ruiz; Cesar Miguel Mejía-Barradas; Rene Domínguez-Rubio; Paloma De la Garza-Montano; Alfonso Alfaro-Rodríguez; Eleazar Lara-Padilla
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 6.  Pharmacotherapy for the management of achalasia: Current status, challenges and future directions.

Authors:  Ammar Nassri; Zeeshan Ramzan
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

7.  Neuronal targeting, internalization, and biological activity of a recombinant atoxic derivative of botulinum neurotoxin A.

Authors:  Sabine Pellett; William H Tepp; Larry H Stanker; Philip A Band; Eric A Johnson; Konstantin Ichtchenko
Journal:  Biochem Biophys Res Commun       Date:  2011-02-01       Impact factor: 3.575

8.  Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A.

Authors:  Jasmin Strotmeier; Stefan Mahrhold; Nadja Krez; Constantin Janzen; Jianlong Lou; James D Marks; Thomas Binz; Andreas Rummel
Journal:  FEBS Lett       Date:  2014-02-25       Impact factor: 4.124

9.  Identification of a Botulinum Neurotoxin-like Toxin in a Commensal Strain of Enterococcus faecium.

Authors:  Sicai Zhang; Francois Lebreton; Michael J Mansfield; Shin-Ichiro Miyashita; Jie Zhang; Julia A Schwartzman; Liang Tao; Geoffrey Masuyer; Markel Martínez-Carranza; Pål Stenmark; Michael S Gilmore; Andrew C Doxey; Min Dong
Journal:  Cell Host Microbe       Date:  2018-01-27       Impact factor: 21.023

Review 10.  Therapeutic use of botulinum toxin in migraine: mechanisms of action.

Authors:  Roshni Ramachandran; Tony L Yaksh
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.